Our research has also revealed that activation of the EGFR/PI3K/Akt signaling pathway is responsible for both EMT-like transformation and anoikis resistance in ACC, pointing to the potential therapeutic value of targeting such pathways in preventing distant metastasis of human ACC. This evidence concerns the gene EGFR and adrenal cortex carcinoma.